Search All News
A clinical trial at Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
In a phase three clinical trial, sorafenib stopped progression of desmoid tumors for two years in 80 percent of patients who completed treatment.
- December 2, 2010
Award Recognizes Distinguished Scientists Annually Since 1967; 42 Past Awardees Have Gone on to Win the Nobel Prize
- October 25, 2010
New Analysis Suggests Exposure in Middle Age May Result in More Risk than Previously Thought
- August 9, 2010
Pilot Study by Columbia University Medical Center Urologic Surgeons Reports on Technology's Potential
- April 30, 2010
- June 10, 2008
- April 24, 2008